References
Schiffrin EL, Amiri F, Benkirane K, Iglarz, M, Diep QN. Peroxisome proliferator-activated receptors: Vascular and cardiac effects in hypertension. Hypertension 2003;42:664–668.
Bulut D, Potthast R, Hanefeld C, Schulz T, Kuhn M, Mugge A. Impaired vasodilator responses to atrial natriuretic peptide in essential hypertension. Eur J Clin Invest 2003;33:567–573.
Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003;23:729–736.
Malik J, Melenovsky V, Wichterle D, et al. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial–FAT). Cardiovasc Res 2001;52:290–298.
Laufs U, Wassmann S, Hilgers S, Ribaudo, N. Bohm, M. Nickenig, G. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 2001;88:1306–1307.
Author information
Authors and Affiliations
Corresponding author
Additional information
Both authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hanefeld, C., Bulut-Streich, N., Bulut, D. et al. Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy. Cardiovasc Drugs Ther 19, 153–155 (2005). https://doi.org/10.1007/s10557-005-0442-y
Issue Date:
DOI: https://doi.org/10.1007/s10557-005-0442-y